Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer
β Scribed by Jose Luis F Duque; Kevin R Loughlin; Rosalyn M Adam; Philip W Kantoff; David Zurakowski; Michael R Freeman
- Book ID
- 117266017
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 147 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract **Background/aims** Vascular endothelial growth factor (VEGF) is a cytokine participating in inflammation with potent endothelial cell effects. It is produced by macrophages, neutrophils and vascular endothelial cells and can alter vessel permeability. BehΓ§et's syndrome is a systemic in
It is known that vascular endothelial growth factor (VEGF) family is an important role in vasculogenesis and angiogenesis. Among the VEGF family members, VEGF-A plays an essential role in angiogenesis. However, the significance of serum levels of other VEGF members (VEGF-C and -D) has been reported